|
Supplier
|
Description
|
Reference
|
| MaybridgeBB
|
3,4-dihydro-2H-1,5-benzodioxepin-7-yl isocyanate, 97%
3D model
NMR 1H CDCl3
Hazard
Risk
Safety
|
|
CC13206CB |
250 MG |
|
CC13206CB |
250 MG |
|
CC13206DA |
1 GR |
|
CC13206DA |
1 GR |
|
CC13206DE |
5 GR |
|
CC13206DE |
5 GR |
|
| matrixswitzerland
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-yl isocyanate |
| |
|
|
| atomole
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-yl isocyanate |
| , 97,0%
|
|
|
| labseeker
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-YL isocyanate |
| , 97.00%
|
|
|
| pipharm
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-YL isocyanate |
| , 97,0%
|
|
|
| carbonesci
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-yl isocyanate |
| , 97.0%
|
|
|
| chemos
|
3,4-Dihydro-(2H)-1,5-benzodioxepin-7-ylisocyanate
|
|
| atomax
|
| 3,4-dihydro-2H-1,5-benzodioxepin-7-ylisocyanate |
| |
|
|
| bepharm
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-yl isocyanate |
| , 97.0%
|
|
|
| hallochem
|
| 3,4-Dihydro-2h-1,5-Benzodioxepin-7-Yl Isocyanate |
| , 99%
|
|
|
| bestchemistry
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-yl isocyanate |
| , 98%
|
|
|
| cnzhongjianti
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-yl isocyanate |
| |
|
|
| chemhere
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-yl isocyanate |
| , 99%
|
|
|
| gs-chem
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-yl isocyanate |
| , 97,0%
|
|
|
| acccorporation
|
| 3,4-dihydro-2H-1,5-benzodioxepin-7-yl isocyanate |
| , > 95%
|
|
|
| conier
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-yl isocyanate |
| , 95%
|
|
|
| apollo
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-yl isocyanate |
| |
3D model
|
|
| chemner
|
| 3,4-Dihydro-2H-1,5-benzodioxepin-7-yl isocyanate |
| , 95%
|
|
|
| chemstep
|
| 2H-1,5-Benzodioxepin, 3,4-dihydro-7-isocyanato- (9CI) |
| |
|
|